Fertility Issues for Childhood Cancer Survivors

When pediatric cancer patients are fighting for their lives, parents have to stay laser-focused on the here and now. As a result, there is often little room for thoughts about the late effects of cancer treatment on children— including fertility preservation for cancer patients. But according to Dr. Sogol Mostoufi-Moab, MD, MSCE, a dual-certified pediatric oncologist and endocrinologist at the Children’s Hospital of Philadelphia, “Nine out of ten children who successfully reach a cure from cancer will develop a chronic condition.” What’s more, endocrine disorders, which can cause infertility, have a 75% prevalence — making them the most common morbidity in childhood cancer survivors. 

Childhood cancer survivors can face challenges years after treatment is complete and full remission is achieved. In this article, we cover fertility issues resulting from common childhood cancer treatments, methods of fertility preservation, and how parents can support their child into adulthood with survivorship care plans. 

Common Childhood Cancer Treatments & How They Can Affect Fertility

There is no such thing as a one size fits all approach to treating childhood cancer. Based on the type of cancer, pediatric oncologists use standard protocols or recommend enrolling on a clinical trial testing a new protocol versus the current standard of care. According to the National Cancer Institute, some of the most common childhood cancer treatments include: 

• Surgery: Unlike a biopsy, where a surgeon makes a minimally invasive incision to remove a piece of tissue for testing, surgery is used to remove a mass (tumor) from the body. Along with the mass, surgeons also remove some of the surrounding tissue (known as the margin) to ensure the surrounding tissue is also free of malignancy. 

• Adverse effects on fertility in both sexes: No adverse effects unless it involves the injury or removal of reproductive organs or secondary complications (results of a surgical procedure that may worsen over time). 

A pregnant woman in a white dress is holding her belly in a field of flowers.

• Chemotherapy: Uses medications administered either intravenously or orally to kill cancer cells. Often, a patient undergoing chemotherapy will have a central venous line (CVL) that exits the chest, or a port, under the skin, where doctors can administer medication and draw blood. A CVL alleviates the need for a patient to undergo multiple needle sticks, and a port reduces the chance of infection in the line, since most regimens require months of treatment.

• Adverse effects on fertility in females: Chemotherapy can affect the viability of the ovaries as it’s considered a gonadotoxic treatment — especially when alkylating chemotherapy agents are used. However, prepubertal ovaries are typically more resistant to chemotherapy damage when compared to post-pubertal ovaries in female children. Sometimes the damage is only temporary, but sometimes treatment can cause permanent damage, affecting a female’s fertility. Some childhood cancer survivors may also experience premature menopause, but younger cancer patients are less likely to experience this as one of the late effects of chemotherapy. If they do, it’s typically many years after cancer treatment is complete, but before the age of 40 years. 

• Adverse effects on fertility in males: Chemotherapy can affect the viability of sperm since it is gonadotoxic. Sometimes this is only temporary, but sometimes treatment can cause permanent damage, affecting a male’s fertility — especially after alkylating chemotherapy agents. Likewise, chemotherapy can inhibit the ability of a male to get and keep an erection. However, most childhood cancer survivors do not experience permanent effects on sexual performance. 

• Radiation therapy: Uses beams of radiation to kill cancer cells. Depending on the type of cancer a patient has, an oncologist may recommend a course of treatment consisting of chemotherapy in conjunction with radiation therapy. 

• Adverse effects on fertility in females: Radiation is gonadotoxic and can affect the ovaries’ viability, especially when a patient receives concentrated radiation to the lower abdominal and pelvic area. Radiation can destroy or damage some or all of a childhood cancer survivor’s eggs, potentially leading to infertility in the future. Females may also experience premature menopause as one of the late effects of radiation. If they do, it’s typically many years after cancer treatment is complete, but before the age of 40 years. 

Additionally, cranial radiation can affect the hypothalamic-pituitary-ovarian axis, affecting the body’s ability to produce the hormones necessary for ovulation.

• Adverse effects on fertility in males: Radiation can affect the viability of sperm, especially when a patient receives concentrated radiation to the lower abdominal and pelvic area as it’s considered a gonadotoxic treatment. Sometimes this is only temporary, but sometimes treatment can cause permanent damage, affecting a childhood cancer survivor’s fertility. Fertility issues are commonly seen in patients who receive low-dose radiation; however, prepubescent males tend to see less damage to their sperm cells. 

Additionally, cranial radiation can affect the hypothalamic-pituitary axis, affecting the body’s ability to produce the hormones necessary for producing sperm. The younger the child, the more radiosensitive their hypothalamic-pituitary axis. 

• Immunotherapy: Stimulates the body’s immune system to kill cancer cells. Like chemotherapy, immunotherapy can be administered intravenously or orally. Some immunotherapy treatments may require an extended hospital stay. 

• Adverse effects on fertility in both sexes:  Currently, there is little longitudinal data that demonstrates how immunotherapy affects, if at all, a childhood cancer survivor’s fertility. If your child is undergoing immunotherapy, it’s important to speak with their oncologist about your concerns regarding fertility preservation for cancer patients. 

• Allogeneic or autologous transplant: Uses peripheral blood CD34+ cells collected by apheresis from a matched donor (allogeneic) or self (autologous). After myeloablative conditioning with chemotherapy, the cells are given by IV infusion, similar to a blood transfusion, to regenerate a healthy immune system. Allogeneic or autologous transplants occur after a patient has already had chemotherapy to reduce the burden of cancer to a minimum, and conditioning regimens can involve very high doses of chemotherapy.

• Adverse effects on fertility in females: Since allogeneic or autologous transplant patients typically undergo multiple rounds of chemo and, in some cases, radiation before transplant, many females do experience permanent infertility due to damaged ovaries. This is especially true for childhood cancer survivors who received total body irradiation.

• Adverse effects on fertility in males: Males who receive allogeneic or autologous transplant have already undergone multiple rounds of chemotherapy and, in some cases, radiation, which can result in permanent infertility. This is especially true for those who received total body irradiation.

Methods of Fertility Preservation for Cancer Patients

Considering a child’s future fertility can feel like a huge responsibility for parents — especially amid aggressive cancer treatment. However, even if parents don’t know if their child will want children of their own in the future, parents should know they have options to explore to preserve their child’s fertility. 

Furthermore, the American Society of Clinical Oncology recommends that oncologists should “be prepared to discuss possible fertility preservation options or refer appropriate and interested patients to reproductive specialists.” Here are some standard methods for fertility preservation for cancer patients and their risks per Dr. Lisa Dillar, MD, Vice-Chair, Department of Pediatric Oncology at Boston Children’s Hospital/Dana-Farber Cancer Institute: 

Female cancer patients

• Oocyte cryopreservation: The removal and freezing of an egg from the ovary. A female must be pubescent or have already undergone puberty for this procedure. Females also have to undergo fertility treatments in preparation for egg retrieval. 

• Embryo cryopreservation: The removal and fertilization of an egg from the ovary. A female must be pubescent or have already undergone puberty for this procedure and undergo fertility treatments for egg retrieval. The egg is fertilized through in-vitro fertilization, resulting in an embryo that is then frozen and can be transferred to a childhood cancer survivor’s uterus or carried by a surrogate later. 

• Ovarian tissue cryopreservation: The removal of the ovarian cortex, where the ovarian follicles exist and typically release eggs during a female’s ovulation. The tissue is frozen and stored and can be re-implanted later. 

A female doctor is showing a model of the female reproductive system to a patient.

Risks of fertility preservation for female cancer patients: 
   • A delayed start to cancer treatment 
  • Procedural risks
   • The social-emotional toll of egg retrieval 
  • Reintroducing neoplasia (malignant cells) 
  • Removal of an ovarian cortex that could later play a role in a female’s fertility
   • Unknown pregnancy success and outcomes

 

Male cancer patients

• Sperm cryopreservation: The production of and freezing of sperm. A male must be post-pubertal for this method. 

• Testicular sperm extraction: The retrieval of sperm through various methods such as a small incision, aspiration, or biopsy of the testicles. This procedure is typically performed when a post-pubertal male cannot produce a semen sample. 

• Testicular tissue cryopreservation: In prepubescent males, this is the removal of testicular tissue and the cells that create sperm (spermatogonia), while pubescent and post-pubescent males will have testicular tissue, spermatogonia and sperm removed and frozen. This treatment is still developing, and there are no known cases of childhood cancer survivors who regained fertility or where pregnancy has been achieved. 

 

Risks of fertility preservation for male cancer patients: 
   • A delayed start to cancer treatment
   • Procedural risks
   • The social-emotional toll of procedures 
  • Damage to the sperm cells
   • Unknown pregnancy outcomes (fetal health) 



How Parents Can Support Their Child Into Adulthood With a Survivorship Care Plan

Making decisions that can impact a child’s future fertility is not easy. Whether or not parents decide to pursue fertility preservation for their child, they should work with their child’s oncologists to compile information about their diagnosis, course of treatment, prognosis, and expected outcome. This information will be of critical importance should a child wish to learn more about their medical history and how it can impact their fertility as an adult. 

If complete remission is achieved, long-term follow-up care for pediatric cancer should be discussed. Parents may consider having their child see a primary care physician that specializes in working with childhood cancer survivors and has experience partnering with oncologists. When it’s developmentally appropriate, kids need to be educated on what they’re going through and what it can mean for their future. 

It’s also helpful to remember that families can be formed in many different ways, so if a childhood cancer survivor’s fertility is permanently impacted, it doesn’t mean they cannot pursue having a family one day if they wish.

Fertility is one critical piece of the overall care of pediatric cancer patients. When you give to Solving Kids’ Cancer, you help advance finding, funding, and advocating for breakthrough treatment options to cure children with childhood cancers — because Every Kid Deserves to Grow Up®. 

A pink button that says `` help fund our research '' on a white background.
A man and a little girl are sitting in front of a wooden wall.

Ahana’s Story of Strength

By duda • November 20, 2024
Ahana’s Story of Strength with High-Risk Neuroblastoma Every day, over 1,000 children worldwide are diagnosed with cancer,1 and for many families, that diagnosis means facing an uncertain future. At just 20 months old, Ahana was diagnosed with a rare and aggressive cancer that had already spread through her small body. Her family’s search for life-saving childhood cancer treatments led them from South Africa to Spain and possibly toward a clinical trial in New York. Ahana’s journey shows the importance of supporting organizations like Solving Kids’ Cancer, which works to find, fund, and advocate for advanced treatments that give hope to families fighting against tough-to-treat rare pediatric cancers.
A poster for 2024 year in review for solving kids ' cancer

2024 Year-in-Review

November 11, 2024
Advancing Childhood Cancer Research: SKC’s 2024 Milestones
A group of children are holding a sign that says `` lace up for kids 2024 ''.

2024 Lace Up for Kids Recap

October 1, 2024
Lace Up for Kids: Your Impact on Childhood Cancer Research At Solving Kids’ Cancer, our mission has always been driven by hope — hope for better treatments, hope for breakthroughs, and most importantly, hope for every child fighting cancer. This year’s Lace Up for Kids campaign was nothing short of inspiring. Together, we’ve raised over $264,000 across the entire campaign, funding innovative childhood cancer research and providing more treatment options for children in need.  From coast to coast, nearly 4,000 participants have stepped up to lace up their gold shoelaces and make a difference. Whether it was through schools, sports teams, or community groups, the show of support has been overwhelming throughout the years. Over 7,823 donations have been made to accelerate new treatments, and the hashtag #CareWearShare has been used 13,864 times, spreading the message far and wide!
A girl is standing in front of a car in a parking lot.

Stories of Impact: Erin Martin

September 2, 2024
Gold Laces for Childhood Cancer Awareness Month: Erin’s Story 
A group of children are standing in a circle with their shoes on the floor.

Smithtown Goes Gold for Childhood Cancer

August 8, 2024
Smithtown Goes Gold for Childhood Cancer Awareness Month!
A poster for lace up for kids with a butterfly on it

Lace Up for Kids 2024

August 6, 2024
Childhood Cancer Awareness Month: Lace Up for Kids 2024
A man standing on top of a mountain with the words osteosarcoma survivor to surgeon dr. kurt weiss ' story

Osteosarcoma Survivor Dr. Kurt Weiss

August 1, 2024
Osteosarcoma Survivor to Surgeon: Dr. Kurt Weiss’ Story
Jacob 's journey : a childhood cancer survivor 's story

National Cancer Survivors Month

May 10, 2024
Jacob’s Journey: A Childhood Cancer Survivor’s Story Every battle has its heroes, and among the bravest are young children like Jacob Mozer, who faced stage 4 high-risk neuroblastoma when he was barely old enough to walk. Diagnosed at only 16 months old, Jacob’s early years were filled with constant medical appointments and intense treatments. Despite these challenges, today, Jacob is a shining example of the remarkable progress in pediatric oncology. He’s not merely surviving; he’s thriving as a pharmacy resident, driven to give back to the medical community that gave him a second chance at life. During National Cancer Survivors Month this June, we honor and celebrate fighters like Jacob who have battled cancer and emerged stronger. This month also serves to amplify the conversation about pediatric cancer survivorship and push for vital research that continues to save lives. Solving Kids’ Cancer (SKC) plays an essential role in this effort, supporting children like Jacob by funding crucial clinical trials that enhance survival rates and improve the quality of life for those fighting fatal childhood cancers.
A close up of a person holding a test tube in a laboratory.

Trailblazing Treatments for Pediatric Brain Tumors

May 2, 2024
Trailblazing Treatments for Pediatric Brain Tumors Picture a fortress built to guard precious treasure but accidentally also keeps out the very allies it needs in a time of crisis. This is the challenge faced by medical researchers when dealing with the brain’s natural defense — the blood-brain barrier — especially in children with brain tumors. At Columbia University Medical Center, Dr. Luca Szalontay is leading the charge to breach this fortress with groundbreaking approaches. Recently, Dr. Timothy Cripe from Solving Kids’ Cancer’s podcast, This Week in Pediatric Oncology (TWIPO) , interviewed Dr. Szalontay to delve deeper into these innovative treatments. This Brain Tumor Awareness Month, we’re shining a light on these important advances in treating children’s cancer. Understanding the Challenge Treating pediatric brain tumors like diffuse midline glioma (DMG) is especially tough because of the brain’s own protective shield, known as the blood-brain barrier. This barrier keeps out most chemotherapy drugs as well as large molecules, like antibodies, making it hard to treat the tumors effectively. Dr. Szalontay describes the dilemma: “Our field hasn’t been able to advance as quickly as it has with leukemias or other solid tumors because the drugs don’t penetrate the brain efficiently.” She adds on the nature of this blood-brain barrier, “It’s evolutionary, very important to protect us from different toxins and harmful agents, but this is a shield which protects the tumor as well.” Even when drugs work well in lab tests, they struggle to get to the tumor in strong enough doses without harming the body. Dr. Szalontay also points out that DMG tumors are found in very sensitive areas of the brain, making traditional surgery or radiation risky because they could damage vital brain functions. This makes finding safe and effective treatments for these tumors even more challenging. So, what’s being done to tackle these obstacles and help kids fight these tumors?
A group of stick figures are holding hands around a globe.

World Health Day: Pediatric Cancer’s Global Divide

April 4, 2024
World Health Day: Pediatric Cancer’s Global Divide Imagine this: Two children, born at the same moment, oceans apart. In a country brimming with medical resources, one child quickly gets top-notch treatment for cancer. Meanwhile, across the globe, the other child faces a drastically different reality, with limited access to basic care. This isn’t just a thought experiment — it’s the harsh truth of pediatric cancer treatment worldwide. Observed every year on April 7, World Health Day shines a light on the mission to make healthcare accessible for all. This day is particularly significant in the context of pediatric cancer, where vast disparities in treatment availability highlight the global challenge of ensuring every child has the opportunity for health and healing. The Stark Contrast in Survival Rates: A Look at Pediatric Cancer Statistics Every day, more than 1,000 children are diagnosed with cancer, and the chances of survival vary greatly depending on where they live.1 Pediatric cancer survival rates serve as a clear indicator of the disparities between high-income countries (HICs) and low- and middle-income countries (LMICs). In wealthier nations such as the United States and Western Europe, the 5-year survival rate for children with cancer is over 80%, thanks to advanced healthcare systems and access to the latest treatments.2 But, here’s a troubling childhood cancer statistic: in LMICs where 80% of children with cancer live, fewer than 20% survive.1 This gap is due to several factors, including late diagnoses or, tragically, no diagnosis at all. Many children succumb to the disease without access to pain medication, and the burdens of travel and the high costs force most families to abandon care. These challenges are compounded by limited access to necessary treatments,3 as well as a lack of specialized equipment and trained healthcare professionals needed for effective pediatric cancer treatment. Addressing this divide requires a concerted global effort to improve early detection, make treatments more affordable, and enhance healthcare infrastructures, giving every child a fair chance to beat cancer. Navigating the Access Maze Access to cancer care shouldn’t be a treasure hunt. Yet, for many in LMICs, it feels like that — a relentless search for something seemingly out of reach. Here’s the reality revealed in childhood cancer statistics worldwide: many areas lack enough doctors who specialize in children’s cancer4 and the prices of cancer drugs can be sky-high.2 Even getting to a hospital can be an ordeal, with some families traveling hundreds of miles. And the financial strain? Devastating. The cost of care can quickly add up to more than a year’s income, forcing households into deep financial distress. In many LMICs, the lack of comprehensive insurance coverage means families are often left to pay for pediatric cancer treatment entirely out-of-pocket.5 Families often face the impossible choice between their child’s health and their financial survival. Solving Kids’ Cancer: Bridging the Gap Solving Kids’ Cancer (SKC) isn’t standing by; we’re on the front lines, actively working to make a difference in the global pediatric cancer landscape. Beyond funding research, advocating for policy changes, and fostering global partnerships, SKC is committed to educating and empowering the community to take action. We understand that while we might not have a global foothold to address every aspect of the pediatric cancer divide directly, there’s power in collective action. Through our efforts, we aim to catalyze advancements in pediatric cancer treatments and care that could dramatically change outcomes for children worldwide. • Research: We direct funds into cutting-edge studies, searching for breakthrough treatments that promise a brighter future for all kids, regardless of where they live. • Advocacy: We advocate for children’s needs by steering research funding towards unmet challenges and collaborating with experts to prioritize all children, including expanding trials to international sites to maximize access.2 • Global Partnerships: We don’t do it alone. By teaming up with researchers, hospitals, and other organizations across the globe, we’ve helped fund clinical trials that have extended to over 250 institutions across 15 countries worldwide . Uniting for a Cause Solving Kids’ Cancer extends its mission beyond research by fostering community and collaboration. Our signature event, Lace Up for Kids , held annually during September Childhood Cancer Awareness Month, is a powerful testament to this mission, drawing communities together to stand in solidarity against childhood cancer. Additionally, supporters can create their own fundraiser and have a platform to engage their local communities, sparking crucial conversations and garnering support for the cause. These initiatives highlight an important fact: While the challenge of pediatric cancer is significant, each of us has a part to play. By working together and supporting each other, we can fund the research needed to possibly change the direction of pediatric cancer treatment and care worldwide. World Health Day: A Chance for Every Child The fight against pediatric cancer is a stark reminder of the work ahead of us.6 It’s a battle that Solving Kids’ Cancer is dedicated to, but we need more than just our efforts — we need a global movement. This World Health Day, let’s rally for every child’s right to fight cancer on an even playing field. Donate today to help fund more innovative research and one day find a cure for childhood cancer — because every child, no matter where they are born, deserves a chance — a chance to fight, a chance to survive, and a chance to thrive.
More Posts